VICP
Price
$1.77
Change
+$0.50 (+39.37%)
Updated
Mar 24 closing price
Capitalization
57.3M
ZLDPF
Price
$68.81
Change
+$2.81 (+4.26%)
Updated
Aug 28 closing price
Capitalization
4.85B
Interact to see
Advertisement

VICP vs ZLDPF

Header iconVICP vs ZLDPF Comparison
Open Charts VICP vs ZLDPFBanner chart's image
Vicapsys Life Sciences
Price$1.77
Change+$0.50 (+39.37%)
Volume$100
Capitalization57.3M
Zealand Pharma A/S
Price$68.81
Change+$2.81 (+4.26%)
Volume$153
Capitalization4.85B
VICP vs ZLDPF Comparison Chart in %
Loading...
ZLDPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
VICP vs. ZLDPF commentary
Sep 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VICP is a Hold and ZLDPF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 02, 2025
Stock price -- (VICP: $1.77 vs. ZLDPF: $68.81)
Brand notoriety: VICP and ZLDPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: VICP: 100% vs. ZLDPF: 28%
Market capitalization -- VICP: $57.3M vs. ZLDPF: $4.85B
VICP [@Biotechnology] is valued at $57.3M. ZLDPF’s [@Biotechnology] market capitalization is $4.85B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VICP’s FA Score shows that 1 FA rating(s) are green whileZLDPF’s FA Score has 2 green FA rating(s).

  • VICP’s FA Score: 1 green, 4 red.
  • ZLDPF’s FA Score: 2 green, 3 red.
According to our system of comparison, ZLDPF is a better buy in the long-term than VICP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ZLDPF’s TA Score shows that 5 TA indicator(s) are bullish.

  • ZLDPF’s TA Score: 5 bullish, 3 bearish.

Price Growth

VICP (@Biotechnology) experienced а 0.00% price change this week, while ZLDPF (@Biotechnology) price change was +12.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.61%. For the same industry, the average monthly price growth was +22.15%, and the average quarterly price growth was +32.80%.

Industries' Descriptions

@Biotechnology (+6.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZLDPF($4.85B) has a higher market cap than VICP($57.3M). ZLDPF YTD gains are higher at: -32.776 vs. VICP (-74.714).
VICPZLDPFVICP / ZLDPF
Capitalization57.3M4.85B1%
EBITDAN/A7.27B-
Gain YTD-74.714-32.776228%
P/E RatioN/A4.75-
RevenueN/A9.11B-
Total CashN/A16.6B-
Total DebtN/A397M-
FUNDAMENTALS RATINGS
VICP vs ZLDPF: Fundamental Ratings
VICP
ZLDPF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
34
Fair valued
PROFIT vs RISK RATING
1..100
10072
SMR RATING
1..100
10019
PRICE GROWTH RATING
1..100
6059
P/E GROWTH RATING
1..100
10025
SEASONALITY SCORE
1..100
5590

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VICP's Valuation (1) in the null industry is somewhat better than the same rating for ZLDPF (34). This means that VICP’s stock grew somewhat faster than ZLDPF’s over the last 12 months.

ZLDPF's Profit vs Risk Rating (72) in the null industry is in the same range as VICP (100). This means that ZLDPF’s stock grew similarly to VICP’s over the last 12 months.

ZLDPF's SMR Rating (19) in the null industry is significantly better than the same rating for VICP (100). This means that ZLDPF’s stock grew significantly faster than VICP’s over the last 12 months.

ZLDPF's Price Growth Rating (59) in the null industry is in the same range as VICP (60). This means that ZLDPF’s stock grew similarly to VICP’s over the last 12 months.

ZLDPF's P/E Growth Rating (25) in the null industry is significantly better than the same rating for VICP (100). This means that ZLDPF’s stock grew significantly faster than VICP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
VICPZLDPF
RSI
ODDS (%)
N/A
Bearish Trend 5 days ago
55%
Stochastic
ODDS (%)
N/A
Bearish Trend 5 days ago
69%
Momentum
ODDS (%)
N/A
Bullish Trend 5 days ago
57%
MACD
ODDS (%)
N/A
Bullish Trend 5 days ago
62%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
17%
Bullish Trend 5 days ago
57%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
15%
Bullish Trend 5 days ago
58%
Advances
ODDS (%)
N/A
Bullish Trend 16 days ago
72%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 5 days ago
63%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ZLDPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RHEP2.000.18
+9.89%
Regional Health Properties, Inc.
CFPZF9.500.02
+0.20%
Canfor Corp.
QUCT1799.96N/A
N/A
Queen City Investments, Inc.
BCHMY7.99N/A
N/A
Bachem Holding AG
DASTF31.28-0.18
-0.58%
Dassault Systemes SA

VICP and

Correlation & Price change

A.I.dvisor indicates that over the last year, VICP has been loosely correlated with DMAC. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if VICP jumps, then DMAC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VICP
1D Price
Change %
VICP100%
N/A
DMAC - VICP
33%
Loosely correlated
-2.73%
GOVX - VICP
31%
Poorly correlated
+0.15%
KALA - VICP
29%
Poorly correlated
+5.95%
CASI - VICP
29%
Poorly correlated
-5.33%
ZLDPF - VICP
28%
Poorly correlated
N/A
More

ZLDPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZLDPF has been loosely correlated with IMRN. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ZLDPF jumps, then IMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZLDPF
1D Price
Change %
ZLDPF100%
N/A
IMRN - ZLDPF
52%
Loosely correlated
+0.55%
MNMD - ZLDPF
32%
Poorly correlated
-9.20%
VICP - ZLDPF
28%
Poorly correlated
N/A
GLSI - ZLDPF
26%
Poorly correlated
+0.17%
LTRN - ZLDPF
23%
Poorly correlated
+0.49%
More